论文部分内容阅读
肝移植是治疗HBV感染后终末期肝病的有效方法,此类患者术后预防乙肝复发成为首要问题。我国现阶段标准的预防肝移植术后乙肝复发的方案仍为小剂量乙型肝炎人免疫球蛋白(HBIG)联合核苷类似物治疗~([1])。HBIG药液较黏稠,注射时常
Liver transplantation is an effective treatment for end-stage liver disease after HBV infection. Prevention of hepatitis B recurrence in such patients is the most important issue. Our current standard of prevention of hepatitis B recurrence after liver transplantation program is still a small dose of hepatitis B human immunoglobulin (HBIG) combined nucleoside analogue treatment ~ ([1]). HBIG liquid is more viscous, often injected